Literatur
Sitaru C, Zillikens D (2005) Mechanisms of blister induction by autoantibodies. Exp Dermatol 14: 861–875
Kottke MD, Delva E, Kowalczyk AP (2006) The desmosome: cell science lessons from human diseases. J Cell Sci 119: 797–806
Jablonska S, Chorzelski TP, Beutner EH, Chorzelska J (1975) Herpetiform pemphigus, a variable pattern of pemphigus. Int J Dermatol 14: 353–359
M Megahed M (2004) Histopathology of blistering disaeses. With clinical, electron microscopic, immunological and molecular biological correlations. Springer, Berlin Heidelberg New York Tokyo, pp 116–121
Ishii K, Amagai M, Komai A et al. (1999) Desmoglein 1 and desmoglein 3 are the target autoantigens in herpetiform pemphigus. Arch Dermatol 135: 943–947
Enk AH, Knop J (1999) Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol 135: 54–56
Mahajan VK, Sharma NL, Sharma RC, Garg G (2005) Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases. Int J Dermatol 44: 821–827
Lapidoth M, David M, Ben-Amitai D et al. (1994) The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study. J Am Acad Dermatol 30: 752–757
Marzano AV, Dassoni F, Caputo R (2006) Treatment of refractory blistering autoimmune diseases with mycophenolic acid. J Dermatolog Treat 17: 370–376
Powell AM, Albert S, Al Fares S et al. (2003) An evaluation of the usefulness of mycophenolate mofetil in pemphigus. Br J Dermatol 149: 138–145
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wosnitza, M., Blazek, C. & Megahed, M. Pemphigus herpetiformis. Hautarzt 59, 459–460 (2008). https://doi.org/10.1007/s00105-008-1574-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-008-1574-3